Tracazolate has primarily [[anxiolytic]] and [[anticonvulsant]] effects, with [[sedative]] and [[muscle relaxant]] effects only appearing at higher doses.<ref>Patel JB, Malick JB. Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolytic agent. ''European Journal of Pharmacology''. 1982 Mar 12;78(3):323-33. {{PMID|6121711}}</ref> It has a unique receptor binding profile involving allosteric modulation of several [[GABAA receptor|GABA<sub>A</sub>]] receptor subtypes, being selective for GABA<sub>A</sub> receptors containing α1 and β3 subunits, but exhibiting different effects depending on the third type of subunit making up the receptor complex.<ref>Thompson SA, Wingrove PB, Connelly L, Whiting PJ, Wafford KA. Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors. ''Molecular Pharmacology''. 2002 Apr;61(4):861-9. {{PMID|11901225}}</ref>
